Il deficit di α1-antitripsina: Lo studio clinico di Brescia

Translated title of the contribution: α1-Antitrypsin deficiency. The Brescia (Italy) clinical study

Laura Pini, Luciano Corda, Mario Malerba, Alessandro Montanelli, Gian Mario Favagrossa, Arturo Terzi, Nadia Marcobruni, Mauro Magoni, Diego Franchini, Alessandro Radaeli, Claudio Tantucci, Vittorio Grassi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In a longitudinal clinical study, two hundred subjects have been evaluated in order to identify α1-antitrypsin deficiency patients. According to their serum α1-antitrypsin levels, they have been divided into three groups: 25 patients with severe deficiency (with both pathological alleles - ZZ, SZ or Z and rare deficiency allele - and, if clinically suggested, to be treated with augmentation therapy), 92 patients with intermediate deficiency (with one pathological allele, to be followed up in order to evaluate the risk to develop deficiency related disease) and 63 healthy subjects (normal alleles MM). They performed lung function test (including cardiopulmonary exercise test and methacholine bronchial challenge) chest X-ray and high resolution computed tomography, blood tests. Severe deficiency patients also performed perfusional lung scan to detect early disorders of blood flow, evaluation of arterial blood gases and liver echotomography. Expiratory flow limitation, the prevalence of vascular disease, the amount of urine elastine products and correlations beetween the amount of nitric oxide exhaled and bronchial hyperresponsiveness have been also investigated. The study showed that in Brescia county the deficiency is more common than expected and that evaluation of liver and vessels might be as useful as lung function tests. In addition, beneficial effect on local system has been observed. The longitudinal study might permit to detect early organ damage and to eliminate additive risk factors.

Original languageItalian
Pages (from-to)352-361
Number of pages10
JournalRecenti Progressi in Medicina
Volume91
Issue number7-8
Publication statusPublished - Jul 2000

Fingerprint

Italy
Alleles
Respiratory Function Tests
Longitudinal Studies
Deficiency Diseases
Methacholine Chloride
Liver
Hematologic Tests
Exercise Test
Vascular Diseases
Ultrasonography
Healthy Volunteers
Nitric Oxide
Thorax
Gases
Tomography
X-Rays
Urine
Lung
Clinical Studies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pini, L., Corda, L., Malerba, M., Montanelli, A., Favagrossa, G. M., Terzi, A., ... Grassi, V. (2000). Il deficit di α1-antitripsina: Lo studio clinico di Brescia. Recenti Progressi in Medicina, 91(7-8), 352-361.

Il deficit di α1-antitripsina : Lo studio clinico di Brescia. / Pini, Laura; Corda, Luciano; Malerba, Mario; Montanelli, Alessandro; Favagrossa, Gian Mario; Terzi, Arturo; Marcobruni, Nadia; Magoni, Mauro; Franchini, Diego; Radaeli, Alessandro; Tantucci, Claudio; Grassi, Vittorio.

In: Recenti Progressi in Medicina, Vol. 91, No. 7-8, 07.2000, p. 352-361.

Research output: Contribution to journalArticle

Pini, L, Corda, L, Malerba, M, Montanelli, A, Favagrossa, GM, Terzi, A, Marcobruni, N, Magoni, M, Franchini, D, Radaeli, A, Tantucci, C & Grassi, V 2000, 'Il deficit di α1-antitripsina: Lo studio clinico di Brescia', Recenti Progressi in Medicina, vol. 91, no. 7-8, pp. 352-361.
Pini L, Corda L, Malerba M, Montanelli A, Favagrossa GM, Terzi A et al. Il deficit di α1-antitripsina: Lo studio clinico di Brescia. Recenti Progressi in Medicina. 2000 Jul;91(7-8):352-361.
Pini, Laura ; Corda, Luciano ; Malerba, Mario ; Montanelli, Alessandro ; Favagrossa, Gian Mario ; Terzi, Arturo ; Marcobruni, Nadia ; Magoni, Mauro ; Franchini, Diego ; Radaeli, Alessandro ; Tantucci, Claudio ; Grassi, Vittorio. / Il deficit di α1-antitripsina : Lo studio clinico di Brescia. In: Recenti Progressi in Medicina. 2000 ; Vol. 91, No. 7-8. pp. 352-361.
@article{65e4bdbea43e43809a581bfc4a322f45,
title = "Il deficit di α1-antitripsina: Lo studio clinico di Brescia",
abstract = "In a longitudinal clinical study, two hundred subjects have been evaluated in order to identify α1-antitrypsin deficiency patients. According to their serum α1-antitrypsin levels, they have been divided into three groups: 25 patients with severe deficiency (with both pathological alleles - ZZ, SZ or Z and rare deficiency allele - and, if clinically suggested, to be treated with augmentation therapy), 92 patients with intermediate deficiency (with one pathological allele, to be followed up in order to evaluate the risk to develop deficiency related disease) and 63 healthy subjects (normal alleles MM). They performed lung function test (including cardiopulmonary exercise test and methacholine bronchial challenge) chest X-ray and high resolution computed tomography, blood tests. Severe deficiency patients also performed perfusional lung scan to detect early disorders of blood flow, evaluation of arterial blood gases and liver echotomography. Expiratory flow limitation, the prevalence of vascular disease, the amount of urine elastine products and correlations beetween the amount of nitric oxide exhaled and bronchial hyperresponsiveness have been also investigated. The study showed that in Brescia county the deficiency is more common than expected and that evaluation of liver and vessels might be as useful as lung function tests. In addition, beneficial effect on local system has been observed. The longitudinal study might permit to detect early organ damage and to eliminate additive risk factors.",
keywords = "α-antitrypsin deficiency, Pulmonary emphysema",
author = "Laura Pini and Luciano Corda and Mario Malerba and Alessandro Montanelli and Favagrossa, {Gian Mario} and Arturo Terzi and Nadia Marcobruni and Mauro Magoni and Diego Franchini and Alessandro Radaeli and Claudio Tantucci and Vittorio Grassi",
year = "2000",
month = "7",
language = "Italian",
volume = "91",
pages = "352--361",
journal = "Recenti Progressi in Medicina",
issn = "0034-1193",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "7-8",

}

TY - JOUR

T1 - Il deficit di α1-antitripsina

T2 - Lo studio clinico di Brescia

AU - Pini, Laura

AU - Corda, Luciano

AU - Malerba, Mario

AU - Montanelli, Alessandro

AU - Favagrossa, Gian Mario

AU - Terzi, Arturo

AU - Marcobruni, Nadia

AU - Magoni, Mauro

AU - Franchini, Diego

AU - Radaeli, Alessandro

AU - Tantucci, Claudio

AU - Grassi, Vittorio

PY - 2000/7

Y1 - 2000/7

N2 - In a longitudinal clinical study, two hundred subjects have been evaluated in order to identify α1-antitrypsin deficiency patients. According to their serum α1-antitrypsin levels, they have been divided into three groups: 25 patients with severe deficiency (with both pathological alleles - ZZ, SZ or Z and rare deficiency allele - and, if clinically suggested, to be treated with augmentation therapy), 92 patients with intermediate deficiency (with one pathological allele, to be followed up in order to evaluate the risk to develop deficiency related disease) and 63 healthy subjects (normal alleles MM). They performed lung function test (including cardiopulmonary exercise test and methacholine bronchial challenge) chest X-ray and high resolution computed tomography, blood tests. Severe deficiency patients also performed perfusional lung scan to detect early disorders of blood flow, evaluation of arterial blood gases and liver echotomography. Expiratory flow limitation, the prevalence of vascular disease, the amount of urine elastine products and correlations beetween the amount of nitric oxide exhaled and bronchial hyperresponsiveness have been also investigated. The study showed that in Brescia county the deficiency is more common than expected and that evaluation of liver and vessels might be as useful as lung function tests. In addition, beneficial effect on local system has been observed. The longitudinal study might permit to detect early organ damage and to eliminate additive risk factors.

AB - In a longitudinal clinical study, two hundred subjects have been evaluated in order to identify α1-antitrypsin deficiency patients. According to their serum α1-antitrypsin levels, they have been divided into three groups: 25 patients with severe deficiency (with both pathological alleles - ZZ, SZ or Z and rare deficiency allele - and, if clinically suggested, to be treated with augmentation therapy), 92 patients with intermediate deficiency (with one pathological allele, to be followed up in order to evaluate the risk to develop deficiency related disease) and 63 healthy subjects (normal alleles MM). They performed lung function test (including cardiopulmonary exercise test and methacholine bronchial challenge) chest X-ray and high resolution computed tomography, blood tests. Severe deficiency patients also performed perfusional lung scan to detect early disorders of blood flow, evaluation of arterial blood gases and liver echotomography. Expiratory flow limitation, the prevalence of vascular disease, the amount of urine elastine products and correlations beetween the amount of nitric oxide exhaled and bronchial hyperresponsiveness have been also investigated. The study showed that in Brescia county the deficiency is more common than expected and that evaluation of liver and vessels might be as useful as lung function tests. In addition, beneficial effect on local system has been observed. The longitudinal study might permit to detect early organ damage and to eliminate additive risk factors.

KW - α-antitrypsin deficiency

KW - Pulmonary emphysema

UR - http://www.scopus.com/inward/record.url?scp=0034221209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034221209&partnerID=8YFLogxK

M3 - Articolo

C2 - 10932919

AN - SCOPUS:0034221209

VL - 91

SP - 352

EP - 361

JO - Recenti Progressi in Medicina

JF - Recenti Progressi in Medicina

SN - 0034-1193

IS - 7-8

ER -